Tag: plans

Strategic appointment strengthens Actelis' commercialization efforts and focus across Federal/Military/Local Gov. and telecommunications markets with proven sales leader bringing over 30 years of experience in defense, government, and carrier sectors

Conference Call Today at 10:00 a.m. Eastern Daylight Time

HONG KONG, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Xtreme Asset Management Limited, a licensed and regulated Hong Kong asset management firm, today announced a major 2025 strategic initiative to strengthen its global investment capabilities and expand access to high-growth sectors for institutional and private clients worldwide.

Katy, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company” or “CWPE”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors that it has reduced its Authorized Shares of Common Stock from 300,000,000 to 150,000,000, a 50% reduction.

DUBLIN, Ireland, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced the signing of a non-binding Letter of Intent (“LOI”) to form a joint venture (“JV”) with a privately-held South Africa-based specialized fuel company (the “Partner”) aimed at delivering a specialized fuel solution for a project in South Africa. The first project for the JV has been awarded to the Partner by a subsidiary of a multinational food and beverage corporation. The proposed transaction aligns with Fusion Fuel’s strategic focus on near-term, revenue-generating, integrated energy investments.

According to Precedence Research, the global energy storage systems market size is worth USD 288.97 billion in 2025 and is forecasted to hit approximately USD 569.39 billion by 2034, expanding at a CAGR of 7.87% from 2025 to 2034. Driven by renewable integration, grid reliability, and EV growth, the market is set for robust expansion through 2034.

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.